vemurafenib,cobimetinib,temsirolimus,atezolizumab,trastuzumab,sunitinib,larotrectinib,pertuzumab,palbociclib,entrectinib,regorafenib,tucatinib,nivolumab,futibatinib,abemaciclib,pembrolizumab,talazoparib,olaparib,ipilimumab
bms,bayer,astrazeneca,pfizer,eli lilly,seagen,merck,otsuka,roche
['mbc', 'breast', 'tapur', 'brca', 'talazo', 'solid tumor']
tapur study: talazoparib may have antitumor activity in range of solid tumors with brca1/2 mutations. #mbc #asco23 #metastaticbreastcancer #clinicaltrials #cancerresearch #denovombc 